ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CVSG Cvs Group Plc

975.00
-44.00 (-4.32%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cvs Group Plc LSE:CVSG London Ordinary Share GB00B2863827 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -44.00 -4.32% 975.00 976.00 984.50 1,040.00 980.00 1,040.00 488,057 16:35:27
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Veterinary Svcs-animal Specs 608.3M 41.9M 0.5843 16.81 704.58M
Cvs Group Plc is listed in the Veterinary Svcs-animal Specs sector of the London Stock Exchange with ticker CVSG. The last closing price for Cvs was 1,019p. Over the last year, Cvs shares have traded in a share price range of 950.00p to 2,226.00p.

Cvs currently has 71,712,970 shares in issue. The market capitalisation of Cvs is £704.58 million. Cvs has a price to earnings ratio (PE ratio) of 16.81.

Cvs Share Discussion Threads

Showing 351 to 373 of 950 messages
Chat Pages: Latest  26  25  24  23  22  21  20  19  18  17  16  15  Older
DateSubjectAuthorDiscuss
31/3/2017
08:22
Welcome back woody! I have also added more recently. Excellent results.
lomax99
31/3/2017
08:06
Bought quite a few this morning in several trades. Foolishly held and sold some years ago, when it reached a consolidation phase, for reasonable gain. Lesson learned, stay with the trend. However i can see this continuing to grow with penetration into Europe going well.

As noted the cash flow is extraordinary and the level of receivables is borne out by this.

Will continue to accumulate now on any weakness despite the quite high per.



woody

woodcutter
31/3/2017
07:28
Excellent set of results. Cash flow growing to service debt and fund on going growth. It remains a long-term hold.
chrisgail
18/2/2017
14:21
Lomax99

Agreed with most of your post but to be fair, Zeus only put that out four months ago and the shares have responded since.

Here at CVS PET HEALTH PLANS are driving the growth so I personally see PVG doing extremely well. They don't have any of their own vets anymore just selling PET HEALTH PLANS for independents on a global platform.

CVS Report and Accounts

The Healthy Pet Club loyalty scheme continued its excellent growth in the year. Over 40,000 pets were added to the scheme increasing membership by over 18.8% and bringing the total membership to 253,000. The scheme provides preventative medicine to our customers' pets as well as a range of discounts and benefits. We gain from improved customer loyalty, the encouragement of clinical compliance, protecting revenue generated from drug sales, and bringing more customers into our surgeries. Monthly subscription revenue generated in the year increased to GBP24.0m (2015: GBP18.8m). At the year end, the monthly run rate represented 12.3% (2015: 13.0%) of practice revenue; however in the like-for-like practices the figure was 16.3% (2015: 13.5%), demonstrating the potential for further subscription revenue within the more recently acquired practices into which Healthy Pet Club is also being introduced.



Like for like 16.3 % and I guess the managements long term target here is for that metric is 25%.

pet lover
18/2/2017
13:59
Horses for courses, CVSG's continued growth looks far more assured, PVG could yet crash and burn.

PVG will shoot into the stratosphere when their model has been proven, if it had already been, and everyone actually believed Zeus's £8-£10M PBT in a few years was a dead cert, then PVG would already be up over 1000%!!

It will be really interesting to see Investec's PVG forecasts (Revenues,PBT for the next few years).

lomax99
18/2/2017
13:52
My ramblings about PETS have come home to roost.One part of the business is doing well dragged down by low margin shop sales.

CVSG being a far better bet.

pet lover
18/2/2017
13:42
The outcome to date.

CVSG has had a very good run of 85%

PVG has done rather more 300%

PETS has done very badly indeed off 15%

pet lover
18/2/2017
13:39
Hi this is my post in full from just short of two years ago.


pet lover - 12 Mar 2015 - 18:09:08 - 279 of 358 CVS Group: VETS,All things bright and beautiful - CVSG

This share has had a great run but for me it's just getting to big and with Slater in its now all in the price.
Have no doubt it will still produce year on great results but at a slower rate.
I never liked Pets At Home as not a pure vets as such so one never knows if one part of the company is holding back another. Also dislike the group that sold out in the IPO asking and getting top wack.

I noticed another vet came to the market last week through the back door Reverse take over.
It's traded under the epic code of PVG.
From what one can read it's had all the growing pains of a small outfit trying to grow very fast.
What caught my eye was that it's not just got 15 vets but also built up a vet buying group plus it sells on behalf of other vets a pet health plan. The gross margins in that part of PVG are very high way higher than the vets themselves.

PVG comes in at £8M and has made a loss to date. It also has some loans that charge 12% linked into the big shareholder.thats one thing I do not think much of I have to say. They have just landed a very high flying non ex director and on the same day the shares shot up.PVG put out the RNS and talked of being a global company.

If any of you have time would you be kind enough to run the slide rule over it TA.

pet lover
18/2/2017
13:36
Berenburg upped their target to £12.

A general comment on values, a prospective PE of 15 suggests there may be some way to run.....

[...]

PS Couldn't post link - proactive investors have a recent article out postulating that the recent acquisition of VCA by Mars in the US might set a new benchmark at 19x EBITDA. CVSG is currently above that, but falls to 15x, and Investec thinks that growth of at least 5% PA is likely for the foreseeable future.

lomax99
11/1/2017
15:25
Like the chart. Have been watching and waiting for confirmation. Have redrawn the consolidation area trendlines, calculated target for Ascending Triangle, and note apex approx 19 Jan.
Overall chart shape has some similarities to CRPR before the recent jump.
Is there an update due?

bamboo2
31/12/2016
18:23
eburne, thanks for posting.
lomax99
30/12/2016
11:48
Looking to expand into Australia, New Zealand and the US:
eburne1960
29/12/2016
17:31
The chart here looks terrific. A new all-time high after a successful retest of £10.
saucepan
13/12/2016
07:58
Pleased to see a reasonable sized placing, at a small discount to the current SP, getting away above £10. Bodes well.
lomax99
24/11/2016
08:35
Good statement.

As is there was not enough to go for in the UK, international expansion is afoot. Hopefully the Netherlands are as pet-loving as the British, and bereft of consolidators taking out practices on low PE's. They will need to scale relatively quickly there to achieve economies of scale, and, of course, will need to tightly manage the process. Potentially exciting times ahead....

lomax99
06/10/2016
13:41
SP seems to be slowly weakening each day.
rjd123
22/9/2016
16:36
Results out in the morning. ..
johnthespacer
11/8/2016
19:16
A nice breakout here. Any serious fall back and I will top up
gswredland
10/8/2016
21:51
No thanks! When I consider CVS's mid-long term potential, holders really would be making a big mistake if they cashed in for a short term gain.
lomax99
10/8/2016
20:09
I've said it before and I'll say it again: wouldn't be surprised if Pets At Home were to have a pop - though would prefer it didn't!
eburne1960
10/8/2016
16:30
What are the chances of a bid here?
gswredland
05/8/2016
09:39
Breaking out here
gswredland
22/3/2016
08:41
Solid progress, the pace of acquisitions may cause short term indigestion. A higher multiple was required for an acquisition of some scale, but adds to their overall offering. A continued focus on successful integration/tight operational management remains key. Happy to add on any worthwhile dip....
lomax99
Chat Pages: Latest  26  25  24  23  22  21  20  19  18  17  16  15  Older

Your Recent History

Delayed Upgrade Clock